Jay Kostman is an Infectious Disease physician affiliated with Philadelphia Fight. OpenAlex indexes 143 publications with 4,879 citations (h-index 38); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1207 Chestnut St Fl 3
Philadelphia, PA 191074131
Telephone
267-725-0252Registry record last updated 17 Mar 2018.
Clinical trials
- Antiviral Activity of Peg-IFN-Alpha-2A in Chronic HIV-1 Infection
Sponsor: The Wistar Institute
- A Study of the Long-Term Outcomes of HIV-Positive Patients
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202515 payments
- Gilead Sciences, Inc.Program year20253 payments
- ABBVIE INC.Program year202420 payments$15,677openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
25.1%Statin5.7%Atorvastatin Calcium49%Rosuvastatin Calcium41%Pravastatin Sodium6%Simvastatin4%Part D<11 patientsCalcium channel blocker3.6%Amlodipine Besylate100%Part D≥26 patients+ 14 more classes in this area
Anti-infectives
21.3%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor6%Tivicay50%Isentress30%Cabenuva12%Juluca9%Part D<11 patientsProtease Inhibitor4.1%Darunavir32%Ritonavir29%Prezcobix26%Prezista13%Part D<11 patients+ 9 more classes in this area
Nervous system
21%Benzodiazepine3.6%Lorazepam48%Clonazepam20%Temazepam14%Alprazolam11%Diazepam8%Part D<11 patientsSSRI3.4%Sertraline Hcl51%Trazodone Hcl27%Citalopram Hbr23%Part D<11 patients+ 18 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 1999–2004 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”